{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T20:26:42Z","timestamp":1795206402472,"version":"4.10.3"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sepsis remains a major clinical challenge, with high mortality and long-term disability despite current interventions. Here, we identify the tissue hormone acyl-CoA-binding protein (ACBP), also known as diazepam-binding inhibitor (DBI), as a biomarker and driver of poor outcome in sepsis. ACBP\/DBI was elevated in the plasma of septic patients and associated with organ dysfunction and increased mortality. In murine models of endotoxemia,\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    infection, and polymicrobial sepsis, genetic deletion or antibody-mediated neutralization of ACBP\/DBI conferred robust protection by dampening cytokine storm and preserving organ function. Across these three models, neutralization of ACBP\/DBI with monoclonal antibodies restored thermoregulation and reduced mortality. Mechanistically, ACBP\/DBI inhibition enhanced resilience to lipopolysaccharide-induced sterile inflammation and improved bacterial clearance by macrophages and granulocytes in vivo and in vitro. These effects were observed in monomicrobial infection models and confirmed by high-dimensional immunophenotyping in a polymicrobial sepsis model. Notably, ACBP\/DBI inhibition could be favorably combined with glucocorticoids, enhancing survival and reversing histopathological, transcriptional or metabolic signatures of septic shock across heart, kidney, liver, lung, spleen and plasma. These findings position ACBP\/DBI as a mechanistic amplifier of sepsis pathophysiology and propose its neutralization, alone or in combination with corticosteroids, as a promising therapeutic strategy to interrupt the fatal trajectory of septic shock.\n                  <\/jats:p>","DOI":"10.1038\/s41392-026-02670-z","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:01:03Z","timestamp":1775131263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation"],"prefix":"10.1038","volume":"11","author":[{"given":"Flavia","family":"Lambertucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Moti\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ux\u00eda","family":"Nogueira-Recalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Mont\u00e9gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"P\u00e9rez-Lanz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Carbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylv\u00e8re","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Aprahamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Sauvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mingoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lachkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-7562","authenticated-orcid":false,"given":"Jonathan","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pietrocola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Maiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Rocha-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Roberto","family":"Roncon-Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vasques-N\u00f3voa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0093-9707","authenticated-orcid":false,"given":"Roberto","family":"Lozano-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Avenda\u00f1o-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"L\u00f3pez-Collazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-9054","authenticated-orcid":false,"given":"Mahmoud","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-4405","authenticated-orcid":false,"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2670_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi, M., Evans, L., Levy, M. & Rhodes, A. Sepsis and septic shock. Lancet 392, 75\u201387 (2018).","journal-title":"Lancet"},{"key":"2670_CR2","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss, R. S. et al. Sepsis and septic shock. Nat. Rev. Dis. Primers. 2, 16045 (2016).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"2670_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"2670_CR4","doi-asserted-by":"crossref","unstructured":"Prism Investigators. Early, goal-directed therapy for septic shock\u2014a patient-level meta-analysis. N. Engl. J. Med. 376, 2223\u20132234 (2017).","DOI":"10.1056\/NEJMoa1701380"},{"key":"2670_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/epidemiologia5030032","volume":"5","author":"L La Via","year":"2024","unstructured":"La Via, L. et al. The global burden of sepsis and septic shock. Epidemiologia 5, 456\u2013478 (2024).","journal-title":"Epidemiologia"},{"key":"2670_CR6","doi-asserted-by":"publisher","first-page":"e0228952","DOI":"10.1371\/journal.pone.0228952","volume":"15","author":"T Rahmel","year":"2020","unstructured":"Rahmel, T. et al. Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: the importance of aftercare. PLoS ONE 15, e0228952 (2020).","journal-title":"PLoS ONE"},{"key":"2670_CR7","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s00134-020-06169-1","volume":"46","author":"NE Hammond","year":"2020","unstructured":"Hammond, N. E. et al. Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial. Intensive Care Med. 46, 1696\u20131706 (2020).","journal-title":"Intensive Care Med."},{"key":"2670_CR8","doi-asserted-by":"publisher","first-page":"107386","DOI":"10.1016\/j.pharmthera.2019.06.008","volume":"208","author":"M-C Tonon","year":"2020","unstructured":"Tonon, M.-C. et al. Endozepines and their receptors: structure, functions and pathophysiological significance. Pharmacol. Ther. 208, 107386 (2020).","journal-title":"Pharmacol. Ther."},{"key":"2670_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13910","volume":"22","author":"L Mont\u00e9gut","year":"2023","unstructured":"Mont\u00e9gut, L. et al. Acyl coenzyme A binding protein (ACBP): an aging- and disease-relevant \u201cautophagy checkpoint. Aging Cell 22, e13910 (2023).","journal-title":"Aging Cell"},{"key":"2670_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.cmet.2019.07.010","volume":"30","author":"JM Bravo-San Pedro","year":"2019","unstructured":"Bravo-San Pedro, J. M. et al. Acyl-CoA-binding protein is a lipogenic factor that triggers food intake and obesity. Cell Metab. 30, 754\u2013767.e9 (2019).","journal-title":"Cell Metab."},{"key":"2670_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2207344119","volume":"119","author":"O Moti\u00f1o","year":"2022","unstructured":"Moti\u00f1o, O. et al. ACBP\/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis. Proc. Natl. Acad. Sci. USA 119, 1\u201312 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2670_CR12","first-page":"1","volume":"16","author":"S Li","year":"2025","unstructured":"Li, S. et al. Atlas of expression of acyl CoA binding protein\/diazepam binding inhibitor (ACBP\/DBI) in human and mouse. Cell Death Dis. 16, 1\u201314 (2025).","journal-title":"Cell Death Dis."},{"key":"2670_CR13","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/s42255-024-01170-0","volume":"6","author":"H Pan","year":"2024","unstructured":"Pan, H. et al. Pathogenic role of acyl coenzyme A binding protein (ACBP) in Cushing\u2019s syndrome. Nat. Metab. 6, 2281\u20132299 (2024).","journal-title":"Nat. Metab."},{"key":"2670_CR14","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.3748\/wjg.v21.i30.9103","volume":"21","author":"G Malaguarnera","year":"2015","unstructured":"Malaguarnera, G. et al. Endozepine-4 levels are increased in hepatic coma. World J. Gastroenterol. 21, 9103\u20139110 (2015).","journal-title":"World J. Gastroenterol."},{"key":"2670_CR15","doi-asserted-by":"publisher","first-page":"1505752","DOI":"10.3389\/fimmu.2024.1505752","volume":"15","author":"S Isnard","year":"2024","unstructured":"Isnard, S. et al. Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity. Front. Immunol. 15, 1505752 (2024).","journal-title":"Front. Immunol."},{"key":"2670_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/v14030453","volume":"14","author":"S Isnard","year":"2022","unstructured":"Isnard, S. et al. Distinct plasma concentrations of acyl-CoA-binding protein (ACBP) in HIV progressors and elite controllers. Viruses 14, 453 (2022).","journal-title":"Viruses"},{"key":"2670_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-024-06633-6","volume":"15","author":"G Anagnostopoulos","year":"2024","unstructured":"Anagnostopoulos, G. et al. Inhibition of acyl-CoA binding protein (ACBP) by means of a GABAAR?2-derived peptide. Cell Death Dis 15, 249 (2024).","journal-title":"Cell Death Dis"},{"key":"2670_CR18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2501584122","volume":"122","author":"L Mont\u00e9gut","year":"2025","unstructured":"Mont\u00e9gut, L. et al. Acyl-CoA-binding protein as a driver of pathological aging. Proc. Natl. Acad. Sci. USA 122, e2501584122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2670_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/SHK.0000000000000560","volume":"45","author":"T Clavier","year":"2016","unstructured":"Clavier, T. et al. Increased hypothalamic levels of endozepines, endogenous ligands of benzodiazepine receptors, in a rat model of sepsis. Shock 45, 653\u2013659 (2016).","journal-title":"Shock"},{"key":"2670_CR20","first-page":"E1000","volume":"6","author":"T Pitre","year":"2024","unstructured":"Pitre, T. et al. Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis. Crit. Care Explor. 6, E1000 (2024).","journal-title":"Crit. Care Explor."},{"key":"2670_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12871-025-03196-7","volume":"25","author":"L Cao","year":"2025","unstructured":"Cao, L. et al. Efficacy and safety of corticosteroids in critically ill patients: a systematic review and meta-analysis. BMC Anesthesiol. 25, 319 (2025).","journal-title":"BMC Anesthesiol."},{"key":"2670_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","volume":"18","author":"JX Li","year":"2022","unstructured":"Li, J. X. & Cummins, C. L. Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions. Nat. Rev. Endocrinol. 18, 540\u2013557 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2670_CR23","first-page":"E1071","volume":"6","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri, D. et al. Adverse effects related to corticosteroid use in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia: a systematic review and meta-analysis. Crit. Care Explor. 6, E1071 (2024).","journal-title":"Crit. Care Explor."},{"key":"2670_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung, C. L. et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 358, 111\u2013124 (2008).","journal-title":"N. Engl. J. Med."},{"key":"2670_CR25","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/s42255-024-01169-7","volume":"6","author":"M Paul","year":"2024","unstructured":"Paul, M. & Nixon, M. ACBP orchestrates the metabolic phenotype in Cushing\u2019s syndrome. Nat. Metab. 6, 2220\u20132221 (2024).","journal-title":"Nat. Metab."},{"key":"2670_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104841","volume":"97","author":"R Lozano-Rodr\u00edguez","year":"2023","unstructured":"Lozano-Rodr\u00edguez, R. et al. The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis. eBioMedicine 97, 104841 (2023).","journal-title":"eBioMedicine"},{"key":"2670_CR27","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.3390\/ijms24119578","volume":"24","author":"L Cai","year":"2023","unstructured":"Cai, L., Rodgers, E., Schoenmann, N. & Raju, R. P. Advances in rodent experimental models of sepsis. Int. J. Mol. Sci. 24, 9578 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2670_CR28","doi-asserted-by":"publisher","first-page":"e156876","DOI":"10.1172\/JCI156876","volume":"132","author":"S Ryu","year":"2022","unstructured":"Ryu, S. et al. Siglec-F-expressing neutrophils are essential for creating a profibrotic microenvironment in renal fibrosis. J. Clin. Investig 132, e156876 (2022).","journal-title":"J. Clin. Investig"},{"key":"2670_CR29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.kint.2022.10.008","volume":"103","author":"JR Privratsky","year":"2022","unstructured":"Privratsky, J. R. et al. A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury. Kidney Int. 103, 514 (2022).","journal-title":"Kidney Int."},{"key":"2670_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107825","volume":"26","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Decoding molecular signature on heart of septic mice with distinct left ventricular ejection fraction. iScience 26, 107825 (2023).","journal-title":"iScience"},{"key":"2670_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41418-024-01410-6","volume":"32","author":"O Moti\u00f1o","year":"2025","unstructured":"Moti\u00f1o, O. et al. ACBP\/DBI neutralization for the experimental treatment of fatty liver disease. Cell Death Differ. 32, 434\u2013446 (2025).","journal-title":"Cell Death Differ."},{"key":"2670_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1080\/15548627.2024.2437649","volume":"21","author":"H Pan","year":"2025","unstructured":"Pan, H. et al. Autophagy-dependent hepatocyte secretion of DBI\/ACBP induced by glucocorticoids determines the pathogenesis of Cushing syndrome. Autophagy 21, 678\u2013680 (2025).","journal-title":"Autophagy"},{"key":"2670_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13613-021-00937-y","volume":"11","author":"H Merdji","year":"2021","unstructured":"Merdji, H., Schini-Kerth, V., Meziani, F. & Toti, F. Long-term cardiovascular complications following sepsis: is senescence the missing link? Ann. Intensive Care 11, 166 (2021).","journal-title":"Intensive Care"},{"key":"2670_CR34","first-page":"780","volume":"17","author":"H Sun","year":"2025","unstructured":"Sun, H. et al. Immunosenescence in sepsis: molecular mechanisms and potential therapeutic targets. Aging Dis 17, 780\u2013811 (2025).","journal-title":"Aging Dis"},{"key":"2670_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/intqhc\/mzy137","volume":"31","author":"CY Huang","year":"2019","unstructured":"Huang, C. Y. et al. Life after sepsis: an international survey of survivors to understand the post-sepsis syndrome. Int. J. Qual. Heal. Care 31, 191\u2013198 (2019).","journal-title":"Int. J. Qual. Heal. Care"},{"key":"2670_CR36","doi-asserted-by":"crossref","unstructured":"Mostel, Z. et al. Post-sepsis syndrome\u2014an evolving entity that afflicts survivors of sepsis. Mol. Med. 26, 6 (2019).","DOI":"10.1186\/s10020-019-0132-z"},{"key":"2670_CR37","doi-asserted-by":"publisher","first-page":"e14354","DOI":"10.1111\/acel.14354","volume":"24","author":"R Lavarti","year":"2025","unstructured":"Lavarti, R. et al. Senescence landscape in the liver following sepsis and senolytics as potential therapeutics. Aging Cell 24, e14354 (2025).","journal-title":"Aging Cell"},{"key":"2670_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/SHK.0000000000002512","volume":"63","author":"M M\u00f6senlechner","year":"2025","unstructured":"M\u00f6senlechner, M. et al. Induction of early pulmonary senescence in experimental sepsis. Shock 63, 448\u2013455 (2025).","journal-title":"Shock"},{"key":"2670_CR39","doi-asserted-by":"publisher","first-page":"9635","DOI":"10.1038\/s41598-025-93815-7","volume":"15","author":"A Stasi","year":"2025","unstructured":"Stasi, A. et al. mTOR Inhibition limits LPS induced acute kidney injury and ameliorates hallmarks of cellular senescence. Sci. Rep. 15, 9635 (2025).","journal-title":"Sci. Rep."},{"key":"2670_CR40","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2147\/IDR.S505836","volume":"18","author":"Z Yan","year":"2025","unstructured":"Yan, Z. et al. Validation of senescence of the role of ATM\/P53 pathway in myocardial senescence in mice with sepsis. Infect. Drug Resist. 18, 1961\u20131974 (2025).","journal-title":"Infect. Drug Resist."},{"key":"2670_CR41","doi-asserted-by":"publisher","first-page":"1500741","DOI":"10.3389\/fragi.2024.1500741","volume":"5","author":"WC Miller","year":"2024","unstructured":"Miller, W. C. et al. Cellular senescence in acute human infectious disease: a systematic review. Front. Aging 5, 1500741 (2024).","journal-title":"Front. Aging"},{"key":"2670_CR42","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.cell.2025.03.011","volume":"188","author":"G Kroemer","year":"2025","unstructured":"Kroemer, G. et al. From geroscience to precision geromedicine: understanding and managing aging. Cell 188, 2043\u20132062 (2025).","journal-title":"Cell"},{"key":"2670_CR43","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuron.2013.04.026","volume":"78","author":"CA Christian","year":"2013","unstructured":"Christian, C. A. et al. Endogenous positive allosteric modulation of GABAA receptors by diazepam binding inhibitor. Neuron 78, 1063\u20131074 (2013).","journal-title":"Neuron"},{"key":"2670_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/bs.apha.2014.10.005","volume":"72","author":"Z Farzampour","year":"2015","unstructured":"Farzampour, Z., Reimer, R. J. & Huguenard, J. Endozepines. Adv. Pharmacol. 72, 147\u2013164 (2015).","journal-title":"Adv. Pharmacol."},{"key":"2670_CR45","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Peripheral gating of mechanosensation by glial diazepam binding inhibitor. J. Clin. Investig. 134, e176227 (2024).","DOI":"10.1172\/JCI176227"},{"key":"2670_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-014-0633-7","volume":"18","author":"T Clavier","year":"2014","unstructured":"Clavier, T. et al. Increased plasma levels of endozepines, endogenous ligands of benzodiazepine receptors, during systemic inflammation: a prospective observational study. Crit. Care 18, 1\u20138 (2014).","journal-title":"Crit. Care"},{"key":"2670_CR47","doi-asserted-by":"crossref","unstructured":"Oh, T. K., Park, H. Y., Han, J. Y. & Song, I. A. Prior benzodiazepine use and mortality among adult patients with sepsis: a retrospective population-based cohort study in South Korea. Int. J. Clin. Pract. 75, e14517 (2021).","DOI":"10.1111\/ijcp.14517"},{"key":"2670_CR48","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s40263-024-01108-w","volume":"38","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Incident benzodiazepine and Z-drug use and subsequent risk of serious infections. CNS Drugs 38, 827\u2013838 (2024).","journal-title":"CNS Drugs"},{"key":"2670_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0162-3109(99)00031-4","volume":"41","author":"EMA Ugaz","year":"1999","unstructured":"Ugaz, E. M. A., Pinheiro, S. R., Guerra, J. L. & Palermo-Neto, J. Effects of prenatal diazepam treatment on Mycobacterium bovis-induced infection in hamsters. Immunopharmacology 41, 209\u2013217 (1999).","journal-title":"Immunopharmacology"},{"key":"2670_CR50","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.vaccine.2010.07.032","volume":"28","author":"HP Huemer","year":"2010","unstructured":"Huemer, H. P. et al. Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression. Vaccine 28, 6152\u20136158 (2010).","journal-title":"Vaccine"},{"key":"2670_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2015.04.001","volume":"282","author":"RD Sanders","year":"2015","unstructured":"Sanders, R. D. et al. Immune cell expression of GABAA receptors and the effects of diazepam on influenza infection. J. Neuroimmunol. 282, 97\u2013103 (2015).","journal-title":"J. Neuroimmunol."},{"key":"2670_CR52","doi-asserted-by":"crossref","unstructured":"Mont\u00e9gut, L. et al. Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer. Oncoimmunology 14, 2528955 (2025).","DOI":"10.1080\/2162402X.2025.2528955"},{"key":"2670_CR53","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N. Engl. J. Med. 385, 1737\u20131749 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2670_CR54","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy, M. M. et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit. Care Med. 31, 1250\u20131256 (2003).","journal-title":"Crit. Care Med."},{"key":"2670_CR55","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00011-014-0766-9","volume":"63","author":"MHP van Lieshout","year":"2014","unstructured":"van Lieshout, M. H. P., van der Poll, T. & van\u2019t Veer, C. TLR4 inhibition impairs bacterial clearance in a therapeutic setting in murine abdominal sepsis. Inflamm. Res. 63, 927\u2013933 (2014).","journal-title":"Inflamm. Res."},{"key":"2670_CR56","doi-asserted-by":"publisher","first-page":"36603","DOI":"10.1074\/jbc.M110.189126","volume":"286","author":"C Van\u2019t Veer","year":"2011","unstructured":"Van\u2019t Veer, C. et al. Delineation of the role of toll-like receptor signaling during peritonitis by a gradually growing pathogenic Escherichia coli. J. Biol. Chem. 286, 36603\u201336618 (2011).","journal-title":"J. Biol. Chem."},{"key":"2670_CR57","doi-asserted-by":"crossref","unstructured":"Nguyen, T., Du, J. & Li, Y. C. A protocol for macrophage depletion and reconstitution in a mouse model of sepsis. STAR Protoc. 2, 101004 (2021).","DOI":"10.1016\/j.xpro.2021.101004"},{"key":"2670_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16596-9","volume":"11","author":"G Boivin","year":"2020","unstructured":"Boivin, G. et al. Durable and controlled depletion of neutrophils in mice. Nat. Commun. 11, 1\u20139 (2020).","journal-title":"Nat. Commun."},{"key":"2670_CR59","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.cmet.2021.07.002","volume":"33","author":"J Vandewalle","year":"2021","unstructured":"Vandewalle, J. et al. Combined glucocorticoid resistance and hyperlactatemia contributes to lethal shock in sepsis. Cell Metab. 33, 1763\u20131776.e5 (2021).","journal-title":"Cell Metab."},{"key":"2670_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02748-8","volume":"11","author":"N Karbian","year":"2020","unstructured":"Karbian, N. et al. Apoptotic cell therapy for cytokine storm associated with acute severe sepsis. Cell Death Dis. 11, 535 (2020).","journal-title":"Cell Death Dis."},{"key":"2670_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum, B. et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res. Notes 7, 1\u201311 (2014).","journal-title":"BMC Res. Notes"},{"key":"2670_CR62","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41418-025-01474-y","volume":"32","author":"U Nogueira-Recalde","year":"2025","unstructured":"Nogueira-Recalde, U. et al. Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis. Cell Death Differ. 32, 1484\u20131498 (2025).","journal-title":"Cell Death Differ."},{"key":"2670_CR63","doi-asserted-by":"crossref","unstructured":"Meng, B. et al. Protocol to monitor cardiac function and hemodynamics in septic rodents. STAR Protoc. 5, 102942 (2024).","DOI":"10.1016\/j.xpro.2024.102942"},{"key":"2670_CR64","doi-asserted-by":"crossref","unstructured":"Mont\u00e9gut, L. et al. High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: evidence for a phylogenetically conserved proaging function of ACBP. Aging Cell 22, e13751 (2023).","DOI":"10.1111\/acel.13751"},{"key":"2670_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-1-0716-3694-7_9","volume":"2769","author":"F Lambertucci","year":"2024","unstructured":"Lambertucci, F. et al. Isolation of primary mouse hepatocytes and non-parenchymal cells from a liver with precancerous lesions. Methods Mol. Biol. 2769, 109\u2013128 (2024).","journal-title":"Methods Mol. Biol."},{"key":"2670_CR66","first-page":"e50586","volume":"77","author":"M Swamydas","year":"2013","unstructured":"Swamydas, M. & Lionakis, M. S. Isolation, purification and labeling of mouse bone marrow neutrophils for functional studies and adoptive transfer experiments. J. Vis. Exp. 77, e50586 (2013).","journal-title":"J. Vis. Exp."},{"key":"2670_CR67","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.immuni.2018.02.002","volume":"48","author":"M Evrard","year":"2018","unstructured":"Evrard, M. et al. Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions. Immunity 48, 364\u2013379.e8 (2018).","journal-title":"Immunity"},{"key":"2670_CR68","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1073\/pnas.122244799","volume":"99","author":"Y Li","year":"2002","unstructured":"Li, Y., Karlin, A., Loike, J. D. & Silverstein, S. C. A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc. Natl. Acad. Sci. USA 99, 8289\u20138294 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2670_CR69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/cdd.2014.169","volume":"22","author":"S Ro\u017eman","year":"2014","unstructured":"Ro\u017eman, S. et al. The generation of neutrophils in the bone marrow is controlled by autophagy. Cell Death Differ. 22, 445 (2014).","journal-title":"Cell Death Differ."},{"key":"2670_CR70","first-page":"1","volume":"14","author":"X Zhang","year":"2008","unstructured":"Zhang, X., Goncalves, R. & Mosser, D. M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 14, 1\u201318 (2008).","journal-title":"Curr. Protoc. Immunol."},{"key":"2670_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.476","volume":"8","author":"E Ferrari","year":"2017","unstructured":"Ferrari, E. et al. Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation. Cell Death Dis. 8, e2544 (2017).","journal-title":"Cell Death Dis."},{"key":"2670_CR72","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.kint.2024.02.020","volume":"105","author":"TT Pieters","year":"2024","unstructured":"Pieters, T. T. et al. Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease. Kidney Int. 105, 1212\u20131220 (2024).","journal-title":"Kidney Int."},{"key":"2670_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1126\/scitranslmed.adl0715","volume":"16","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Acyl-CoA binding protein for the experimental treatment of anorexia. Sci. Transl. Med. 16, 11 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2670_CR74","doi-asserted-by":"crossref","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","DOI":"10.1038\/s41598-017-17204-5"},{"key":"2670_CR75","doi-asserted-by":"publisher","first-page":"F674","DOI":"10.1152\/ajprenal.00196.2020","volume":"319","author":"SM Sears","year":"2020","unstructured":"Sears, S. M. et al. C57BL\/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury. Am. J. Physiol. Ren. Physiol. 319, F674\u2013F685 (2020).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"2670_CR76","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00011-013-0603-6","volume":"62","author":"Z Liu","year":"2013","unstructured":"Liu, Z. et al. Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice. Inflamm. Res. 62, 499\u2013506 (2013).","journal-title":"Inflamm. Res."},{"key":"2670_CR77","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2670_CR78","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq-A Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"2670_CR79","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2670_CR80","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"2670_CR81","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1002\/imt2.177","volume":"3","author":"CH Gao","year":"2024","unstructured":"Gao, C. H. et al. ggVennDiagram: Intuitive Venn diagram software extended. iMeta 3, e177 (2024).","journal-title":"iMeta"},{"key":"2670_CR82","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere, U. et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191\u2013W198 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2670_CR83","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"2670_CR84","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"2670_CR85","doi-asserted-by":"publisher","first-page":"e007117","DOI":"10.1136\/jitc-2023-007117","volume":"11","author":"M Perez-Lanzon","year":"2023","unstructured":"Perez-Lanzon, M. et al. New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma. J. Immunother. Cancer 11, e007117 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2670_CR86","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1093\/bioinformatics\/bty344","volume":"34","author":"A Mock","year":"2018","unstructured":"Mock, A. et al. MetaboDiff: an R package for differential metabolomic analysis. Bioinformatics 34, 3417\u20133418 (2018).","journal-title":"Bioinformatics"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02670-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02670-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02670-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:03:23Z","timestamp":1775135003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02670-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2670"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02670-z","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.M., M.A., O.M., and G.K. are the inventors of patents covering the therapeutic utility of ACBP\/DBI neutralization. I.M. is a consultant for Osasuna Therapeutics. G.K. has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Sutro, Tollys, and Vascage. G.K. is on the Board of Directors of the Bristol Myers Squibb Foundation France. G.K. is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics, and Therafast Bio. G.K. is on the scientific advisory boards of Hevolution, Institut Servier, and Rejuveron Life Sciences\/Centenara Labs AG. G.K. is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis, and metabolic disorders. G.K. is a member of the Editorial Board of Signal Transduction and Targeted Therapy, yet was not involved in the peer review or the decision-making of the article. G.K.\u2019s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim. G.K.\u2019s wife, Laurence Zitvogel, has held research contracts with Glaxo Smith Kline, Incyte, Lytix, Kaleido, Innovate Pharma, Daiichi Sankyo, Pilege, Merus, Transgene, 9 m, Tusk, and Roche, was on the Board of Directors of Transgene, is a co-founder of everImmune, and holds patents covering the treatment of cancer and the therapeutic manipulation of the microbiota. The funders had no role in the design of the study, the writing of the manuscript, or the decision to publish the results. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}